Search Results - "Eisen, Andrea F"

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline by Brackstone, Muriel, Baldassarre, Fulvia G., Perera, Francisco E., Cil, Tulin, Chavez Mac Gregor, Mariana, Dayes, Ian S., Engel, Jay, Horton, Janet K., King, Tari A., Kornecki, Anat, George, Ralph, SenGupta, Sandip K., Spears, Patricia A., Eisen, Andrea F.

“…PURPOSE To provide recommendations on the best strategies for the management and on the best timing and treatment (surgical and radiotherapeutic) of the axilla…”
Get full text

Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer by Dayes, Ian S, Metser, Ur, Hodgson, Nicole, Parpia, Sameer, Eisen, Andrea F, George, Ralph, Blanchette, Phillip, Cil, Tulin D, Arnaout, Angel, Chan, Adrien, Levine, Mark N

“…PURPOSEPatients with locally advanced breast cancer (LABC) typically undergo staging tests at presentation. If staging does not detect metastases, treatment…”
Get full text

Impact of 18 F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer by Dayes, Ian S, Metser, Ur, Hodgson, Nicole, Parpia, Sameer, Eisen, Andrea F, George, Ralph, Blanchette, Phillip, Cil, Tulin D, Arnaout, Angel, Chan, Adrien, Levine, Mark N

“…Patients with locally advanced breast cancer (LABC) typically undergo staging tests at presentation. If staging does not detect metastases, treatment consists…”
Get full text

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2 by Phillips, Kelly-Anne, Kotsopoulos, Joanne, Domchek, Susan M, Terry, Mary Beth, Chamberlain, James A, Bassett, Julie K, Aeilts, Amber M, Andrulis, Irene L, Buys, Saundra S, Cui, Wanda, Daly, Mary B, Eisen, Andrea F, Foulkes, William D, Friedlander, Michael L, Gronwald, Jacek, Hopper, John L, John, Esther M, Karlan, Beth Y, Kim, Raymond H, Kurian, Allison W, Lubinski, Jan, Metcalfe, Kelly, Nathanson, Katherine L, Singer, Christian F, Southey, Melissa C, Symecko, Heather, Tung, Nadine, Narod, Steven A, Milne, Roger L

“…It is uncertain whether, and to what extent, hormonal contraceptives increase breast cancer (BC) risk for germline or mutation carriers. Using pooled…”
Get full text

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY by Balmaña, Judith, Fasching, Peter A., Couch, Fergus J., Delaloge, Suzette, Labidi-Galy, Intidhar, O’Shaughnessy, Joyce, Park, Yeon Hee, Eisen, Andrea F., You, Benoit, Bourgeois, Hughes, Gonçalves, Anthony, Kemp, Zoe, Swampillai, Angela, Jankowski, Tomasz, Sohn, Joo Hyuk, Poddubskaya, Elena, Mukhametshina, Guzel, Aksoy, Sercan, Timcheva, Constanta V., Park-Simon, Tjoung-Won, Antón-Torres, Antonio, John, Ellie, Baria, Katherine, Gibson, Isabel, Gelmon, Karen A.

“…Purpose The interim analysis of the phase IIIb LUCY trial demonstrated the clinical effectiveness of olaparib in patients with germline BRCA-mutated (gBRCAm),…”
Get full text

Measurement of recombinase activity in a set of related Abelson murine leukemic virus pre-B cell lines: DJ/DJ lines have more recombinase activity than do VDJ/VDJ lines by Eisen, A F, Atkinson, M J, Celler, J W, Paige, C J, Wu, G E

“…The VDJ recombination potential of a number of Abelson murine leukemic virus transformed fetal liver cell lines derived from (C57BL/6 x BALB/c) F1 mice was…”
Get more information